International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 2 : 3288-3292
Research Article
A Prospective Study on Postpartum Intrauterine Contraceptive Devices (PPIUCD) As a Method of Contraception at A Tertiary Care Centre
 ,
 ,
Received
March 16, 2026
Accepted
April 8, 2026
Published
April 23, 2026
Abstract

Background: Postpartum family planning plays a crucial role in reducing unintended pregnancies and improving maternal and child health outcomes. The postpartum intrauterine contraceptive device (PPIUCD) is a safe, effective, and reversible method of contraception that can be inserted immediately after delivery.

Objectives: To evaluate the awareness, acceptance, safety, efficacy, complications, continuation, and expulsion rates of PPIUCD (Cu-T) among women delivering at a tertiary care centre.

Methods: A prospective observational study was conducted at GMERS Medical College and Hospital, Sola, Ahmedabad, over a period of 24 months. A total of 333 women who consented to PPIUCD insertion were included. Follow-up assessments were carried out at 6 weeks, 6 months, and 1 year to evaluate outcomes including complications, expulsion, and continuation rates.

Results: Out of 5565 deliveries, 1302 women accepted PPIUCD insertion, giving an insertion rate of 23.39%. The majority of participants (77.5%) were aged 21–30 years, and 72.4% belonged to urban areas. Nearly 46.5% of women had not used any contraceptive method previously, and 72.7% had no prior knowledge of PPIUCD. Most insertions occurred during caesarean section (49.8%) or immediately postpartum. Continuation rates were high at 94.4%, 94.41%, and 96% at 6 weeks, 6 months, and 1 year respectively. Expulsion rates remained low (2.12% at 6 weeks, 2.54% at 6 months, and 1.14% at 1 year). The majority of women experienced no complications, with minor issues such as string problems, abdominal pain, and bleeding reported in a small proportion.

Conclusion: PPIUCD is a safe, effective, and reliable method of postpartum contraception with high continuation rates and minimal complications. Despite its advantages and free availability, its utilization remains suboptimal. Increasing awareness, improving counselling, and strengthening training programs for healthcare providers can enhance its acceptance and use

Keywords
INTRODUCTION

Postpartum family planning is essential for reducing unintended pregnancies. PPIUCD is a safe and effective ,reversible contraceptive method. It is a Prospective observational study among 333 women accepting PPIUCD insertion. Insertion rate was 23.39%. Expulsion rates remained low. PPIUCD is a reliable postpartum contraceptive method with minimal complications. India continues to face high unmate need for contraceptions. PPIUCD offers immediate postpartum contraception with high efficiency and convenience before discharge.

 

AIMS AND OBJECTIVES

Study to evaluate the awareness, acceptance, Safety, Efficacy, complications and expulsion rate of postpartum intrauterine contraceptive devices(PPIUCD CU-T).

 

PRIMARY OBJECTIVE: To evaluate safety and efficacy of postpartum IUCD(CU-T).

 

SECONDARY OBJECTIVES:

1) To determine incidence rate

2) To determine rate of occurrence of complications

3) To determine incidence of DUB

4) To determine continuation rate

5) To evaluate failure rate

6) To determine expulsion rate

 

MATERIAL AND METHOD

A prospective observational study was conducted at GMERS MEDICAL COLLEGE AND HOSPITAL,SOLA. Women delivery at the institute and consenting for PPIUCD were included in the study. Follow up visits were scheduled at 6 week, 6 Months and 1 year.

 

STUDY DESIGN

  • It is a observational study approved by Ethical committee of hospital.
  • The study was conducted over period of 24 months.
  • The data was collected from labour room record register for comparison.
  • All patients fulfilling inclusion criteria were included in the study.

 

SAMPLE SIZE:

The sample size will consist of all the patients undergoing PPIUCD(CU-T).

Insertion in the time frame of this study(June 2022 to June 2023).

Sample size: according to below study prevalence of acceptance rate of PPIUCD was 38% (Kant et al) [1]

Where p= Prevalence of acceptance rate of PPIUCD.

q= 1-p

I= Relative allowable Error

Sample size= 4*38*62/0.57=290

Taking 15% lost to follow up= 43

Sample size= 290+43=333

 

STUDY DURATION

From JUNE 2022 to JUNE 2024.

 

STUDY POPULATION

Women opted for insertion of IUCD(Cu T) in labour room of obstetrics and gynaecology department, Sola. Women who were delivered vaginally and by caesarean section fulfilling the inclusion criteria in GMERS MEDICAL COLLEGE AND HOSPITAL,SOLA, AHMEDABAD.

 

INCLUSION CRITERIA

All obstetric patients who were willing for postpartum intrauterine contraceptive device coming to labour room.

 

EXCLUSION CRITERIA

  • Patient who does not give consent
  • Fever during labour and delivery (Temp>38°celsius)
  • Anemia (Hb<8gm/dl)
  • Known to have ruptured membranes for>18hrs prior to delivery.
  • Known uterine abnormalities eg. Bicornuate/Septate uterus, uterine myoma.
  • Manual removal of placenta
  • Unresolved postpartum haemorrhage (PPH) requiring use of additional oxytocic agents in addition to active management of third stage of labour
  • Liver or Renal dysfunction
  • Diabetes mellitus
  • Intrauterine fetal death
  • Having active sexually transmitted disease and other genital tract infection or high risk of sexual transmitted disease.

 

 

OBSERVATION AND RESULT

Key demographic patterns, awareness, insertion timing and complications are summarised.

 

TABLE 1: PERCENTAGE OF PPIUCD

TOTAL NO OF DELIVERIES

TOTAL NO OF PPIUCD INSERTION

PERCENTAGE (%)

5565

1302

23.39%

 

Out of total 5565 deliveries (including both vaginal and caesarean section),PPIUCD were inserted among 1302(23.39%) women. Despite the fact that the government offer IUCD services free of cost and IUCD is one of the most effective, safe and reversible contraceptive method, it still remains largely underutilised.

 

TABLE 2:  AGE(IN YEARS) GROUP OF WOMEN IN THE STUDY

Age

No. Of  women

Percentage (%)

<= 20yrs

39

11.7%

21-30yrs

258

77.5%

31-40yrs

35

10.5%

>40yrs

1

0.3%

 

In present study, majority of the women (77.5%) belong to the age group of 21-30 years which is most fertile age group.

 

Mean age of study is 25.85 years.

 

TABLE 3: TYPE PF RESIDENCE

Residence

No. Of Women

Percentage (%)

Urban

241

72.4%

Rural

92

27.6%

 

In the present study, majority of women(72.4%) belonged to the urban area and (27.6%) belonged to rural areas.

 

TABLE 4: PREVIOUS CONTRACEPTIVE METHODS USED BY WOMEN

Name of Method

No. Of Women

Percentage (%}

Natural

130

39

OCP

10

3

Male Condom

31

9.3

IUCD

3

0.9

DMPA

4

1.2

Not Used

155

46.5

 

Above table shows different types of contraceptive methods used by the women. Majority of women (46.5%) did not use any Contraceptive method. Natural Contraceptive method was opted by 39% of the women.

 

                                          TABLE 5: PPIUCD EXPULSION RATE AT FOLLOW UP

Sr. No.

Time of Follow up

Expulsion No.

Expulsion(%)

01

At 6 week

5

2.12%

02

At 6 Month

5

2.54%

03

At 1 year

2

1.14%

 

The table above shows expulsion rate over time of Follow-up. The incidence reported was low. The PPIUCD expulsion rates at 6 week, 6 Months and  1 year were 2.12%, 2.54% and 1.14% respectively.

 

TABLE 6: COMPLICATION PF PPIUCD INSERTION

Follow-up Findings

At 6 weeks

At 6 Months

At 1 Year

 

No.

(%)

NO.

(%)

No.

(%)

No Complications

197

83.83%

166

84.86%

142

81.14%

Bleeding

5

2.12%

6

2.98%

7

4%

Expulsion

5

2.12%

5

2.54%

2

1.14%

Removal

8

3.40%

6

3.04%

5

2.86%

Thread not seen

4

1.7%

4

2.03%

7

4%

Local infection

6

2.57%

5

2.54%

7

4%

Abdominal pain

8

3.4%

7

3.54%

6

3.43%

String problem

11

4.68%

5

2.54%

4

2.29%

 

The above table shows the complications reported by patients. All the patients were followed up at hospital at 6 week, 6 Months and 1 year.

 

At 6 weeks, the most common complication was a string problem, affecting (4.68%) ( No-11) of women, followed by abdominal pain. In (3.4%) (No-8), local infection in (2.57%) (No-6) and both expulsion and dysfunctional uterine bleeding (DUB) in (2.12%) (No-5) of women.

 

At 6 Months, the most common complaint was abdominal pain, affecting (3.54%) (No-7) women, followed by DUB in (2.98%) (No-6). Other issues included string problems, expulsion and local infection, each affecting (2.54%) (No-5) of women and missing thread in (2.03%) (No-4).

 

At 1 Year, the most common complaint were bleeding per vaginum, missing thread and local infection, each affecting (4%) (No-7) of women. This was followed by abdominal pain in (3.43%) (No-6), string problem in (2.29%) (No-4) and Expulsion in (1.14%) (No-2).

 

TABLE 7: COMPARATIVE ANALYSIS REMOVAL RATE IN VARIOUS STUDY

STUDY

YEAR

REMOVAL RATE OF IUCD

Gupta et al

2013

5.6%

Mohan H et al

2015

6.5%

Barala et al

2016

6.12%

Kavitha N S et al

2016

7.57%

Singh U et al

2017

4.41%

Present study

2024

3.79%

 

DISCUSSION AND RESULT

The present study ,”A Prospective Study on Postpartum Intrauterine Contraceptive Devices as a Method of Contraception at a Tertiary Care Centre” was performed on 333 patients. This Prospective observational Study was conducted at GMERS MEDICAL COLLEGE AND HOSPITAL,SOLA, AHMEDABAD. Between June 2022 and June 2023,the study included 333 women who had undergone postpartum intrauterine contraceptive devices(PPIUCD) insertion.

  • PPIUCD insertion was 23.39% among total deliveries during the study period.
  • The majority of women (77.5%) belonged to the age group of 21-30 years.
  • Most women (72.4%) were from urban areas.
  • Among the women who had a PPIUCD insertion,40.54% were illiterate.
  • In our study, acceptance of PPIUCD was high (36.6%) among 2nd para women and most of them (80.78%) were housewives.
  • In our study, acceptance of PPIUCD was higher among women with a last childbirth>3 years ago(43.54%) and 0-2 years ago (28.52%).
  • The majority of women(46.5%) has not used any Contraceptive method previously.
  • Prior to study,(72.7%) of the women had no knowledge of the PPIUCD.
  • The majority of women(45.9%) were counselled during early labour.
  • In the present study,(49.8%) were underwent PPIUCD Insertion during caesarean section and (50.2%) were underwent PPIUCD insertion after vaginal delivery.
  • In the present study,(49.8%) of PPIUCD insertion were performed intraopeatively during caesarean section, (30%) were done immediately after vaginal delivery and (20.1%) were performed within 48 hours of vaginal delivery.
  • Among women who accepted PPIUCD,(49.8%) did not wish for further conception.
  • Safety and reversibility were the main reasons for the higher rate (39.9%) of PPIUCD insertion during the postpartum period.
  • The continuation rates of PPIUCD were 94.4% At 6 week, 94.41% at 6 Months and 96% at 1 year.
  • The expulsion rates for PPIUCD were 2.12% at 6 weeks, 2.54% at 6 Months and 1.14% at 1 year.
  • In the present study the majority of women came for regular follow up at 6 weeks, 6 Months and 1 year with follow up rates of 70.57%, 59.16% and 52.55% respectively.
  • At 6 weeks, 83.83% of women had no complications
  • Of those who did experience problems, string issues were reported in 4.68% of cases and abdominal pain was noted in 3.4% of women.
  • At 6 Months, the majority of women (84.86%) did not develop any complications. Of those who did experience problems, abdominal pain was noted in 3.55% of women.
  • At 1 year, the majority of women (81.14%) did not develop any complications. Of those who did experience problems, local infection was noted in 4% women.

 

CONCLUSION

PPIUCD is safe, highly effective and reliable Contraceptive method with several advantages, including easy insertion, minimal impact on breastfeeding, cost effectiveness, relief of overcrowded outpatient facilities and protection against unwanted pregnancies and abortions. In the realm of Postpartum Family Planning, PPIUCD is promising approach. The Government of India advocates for free post placental and postpartum IUCD insertion services. However despite being offered at no cost and recognised as one of the most effective, safe and  reversible contraceptive method, IUCD remains largely underutilised. The Government must develop strategies to raise public awareness of PPIUCD through various programmes and media outlets. Additionally, The Government-Led training on PPIUCD, focusing on counselling methods, Insertion techniques and proper follow-up will enhance healthcare providers’ knowledge and skills, further promoting PPIUCD use.

 

REFERENCES

  1. Kant S, Archana S, Singh AK, Ahamed F, Haldar P. Acceptance rate , probability of follow-up and expulsion of postpartum intrauterine contraceptive device offered at two primary health centres,North I dia. J Family Med Prime Care 2016;5:770-6.
  2. Shukla M, Qureshi S,Chandrawati. Post-placental intrauterine device insertion—a five year experience at a tertiary care centre in North India. India J med Res.2012 sep;136(3):432-5. PMID:23041736; PMCID: PMC3510889.
  3. WHO (1970). Techn. Rep. Ser. No.442. Available at:http://www.who.int/biologicals/technical_report_series/en/.
  4. Efficacy and safety of postpartum intrauterine contraceptive devices(PPIUCD) insertion- A prospective study. nNekma Agrawal,Manisha Gupta, Alpana Agrawal, Amita Sharma; Santosh University of journal of Health Sciences 2017;3(1):20-23.

 

Recommended Articles
Research Article Open Access
Evaluation of Fetal Biometry Parameters in Predicting Gestational Age and Growth Abnormalities
2026, Volume-7, Issue 2 : 3361-3367
Research Article Open Access
Role of Fetal Echocardiography in Early Detection of Congenital Heart Diseases: A Prospective Study
2026, Volume-7, Issue 2 : 3332-3339
Research Article Open Access
Negative Pressure Wound Therapy with Delayed Closure Versus Primary Closure in Perforation Peritonitis: A Randomized Controlled Trial
2026, Volume-7, Issue 2 : 3347-3353
Research Article Open Access
Optimal Combined Anteversion in Total Hip Replacement for Indian Population: A Prospective Functional Outcome Study
2026, Volume-7, Issue 2 : 3293-3297
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 2
Citations
5 Views
6 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved